China Non-Invasive Prenatal Testing Market Projected to Reach USD 825 million at a 6.4% CAGR by 2028

DELHI, India - June 13, 2023 - PRLog -- The report offers the most up–to–date industry data on the actual market situation and future outlook for the China non-invasive prenatal testing market. The report also provides up–to–date historical market size data for the period 2018 – 2021 and an illustrative forecast to 2028 covering key market aspects like market value and volume for non-invasive prenatal testing in China.

The report contains a granular analysis of the present industry situations, market demands, reveals facts on the market size, NIPT test volume, revenues and provides forecasts through 2028. The report also includes an assessment of comparative test analysis by companies. It also covers reimbursement patterns and offers a clear view of the regulatory landscape in the China non–invasive prenatal testing market. Key trends in terms of collaboration deals, partnerships, mergers & acquisitions, venture capital investment, distribution, and licensing agreements are analyzed in detail. The report also explores the detailed description of market drivers and inhibitors of the China non–invasive prenatal testing market.

The report concludes with the profiles of major players in the China non–invasive prenatal testing market. The key market players are evaluated on various parameters such as business overview, product outlook, and key development in the non–invasive prenatal testing market in China.

This Comprehensive China Non-Invasive Prenatal Testing Market Research Report Provides:

• To Analyse the Historical Growth in the Market Size of the China Non–Invasive Prenatal Testing Market from 2018 to 2021
• To Estimate and Forecast the Market Size of the China Non–Invasive Prenatal Testing Market from 2022 to 2028 and Growth Rate until 2028
• Evaluates the Number of NIPT Tests Performed in China with Six Years Forecast
• Assessment of Market Potential and Opportunities for this Innovation-Driven China Non–Invasive Prenatal Testing Market with Six Years Forecast
• Meticulously Assesses the Overall China Potential Non–Invasive Prenatal Testing (NIPT) Volume and Future Trends
• Detailed Insights into the Regulatory Framework of the China Non–Invasive Prenatal Testing Market
• Features Reimbursement Patterns of the China Non–Invasive Prenatal Testing Market
• Tracks Competitive Developments, Approaches, Recent Industry Developments, Mergers & Acquisitions, Collaboration Deals, Partnership Deals, Distribution, Exclusive, and Licensing Agreement
• A Comprehensive List of the Key Players Along with the Analysis of their Current NIPT Test Portfolios, Business Overview, and Recent Development

The Leading Companies for the China Non–Invasive Prenatal Testing Market are Listed Below:

• Berry Genomics
• BGI Diagnosis Co. Ltd.
• Basetra Medical Technology Co. Ltd.

More Details @ https://dpiresearch.com/china-non-invasive-prenatal-testi...